Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: A retrospective study of routine clinical use (ANEMONE)
European Journal of Clinical Microbiology & Infectious Diseases | Aug 16, 2018
Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn’s disease patients: A meta-analysis
European Journal of Gastroenterology & Hepatology | Aug 03, 2018
Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality
European Journal of Gastroenterology & Hepatology | Aug 03, 2018
Early treatment response predicts outcome in paediatric ulcerative colitis: Gastroenterology: Inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition | Jul 31, 2018